Search 

Oppilotech develops first-in-class drugs. We believe that target selection is the most important decision we make in drug discovery – a selective high-quality molecule will never become a drug if it is modulating the wrong target. Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class drug targets and to develop novel modes of action drugs modulating the identified targets. We undertake both the target selection and develop the drugs against the identified target. We initially focused our modelling efforts on E.coli identifying several first-in-class antibacterial drug targets and generated active chemical matter against them. The company intends to develop these programmes towards the clinic. We are now expanding into pathways in human cells allowing us to address a wider range of diseases including cancer (e.g. DNA Damage Response) and inflammation.

Pebmond Associates – whether you consider your project or company a Pebble or a Diamond – Our strategic advice and business services for life-science and healthcare organisations adds “Multifaceted Value®”

Strategy, Business Development and Licensing is our focus – whether it is support to acquire, divest or license a product or project -  independent eyes and ears on your company strategy, direction, future plans, project prioritisation or even just general brainstorming – or building your team’s skills in these areas by coaching, face-to-face training, lectures, webinars or e-learning. We do all that - and more importantly, smile at the same time.

Precision for Medicine is an industry-leading global CRO designed
specifically to apply a biomarker-focused, precision medicine
approach to therapeutic development.
What sets us apart is an end-to-end harmonized interconnected
approach to novel and adaptive laboratory and translational
research and complex biomarker trials coupled with expertise in kit
development, logistics, and sample management, and data sciences.
This convergence of trials, labs, and data sciences is driving faster
clinical development and approval.
We apply our expertise to trials at all stages, from early development
through approval.
For more information, please visit: www.precisionformedicine.com

Research Donors collects, processes and delivers human blood biospecimens that meet the most demanding research requirements. With a diverse community of  over 2500 donors, we can meet any donor specification as required by your project. Fresh HLA typed human leukopaks, PBMCs, whole blood and blood derivatives, all consented for commercial and genetic research, can be delivered within 24 hours of collection across Europe.

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. 

Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs.

Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes.

Our international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval.

Our scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development.  Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.

At Scendea we collaborate, innovate, and together with our clients, we succeed.